Suzhou Ju Microbial Technology

Ju Microbial Technology is a clinical-stage biotechnology company headquartered in Suzhou, China, dedicated to the discovery and development of Live Biotherapeutic Products (LBPs). The company utilizes a proprietary anaerobic microbial technology platform to isolate and engineer specific bacterial strains from the human gut microbiome that possess therapeutic potential. Their lead program, JM-001, is designed to modulate the tumor microenvironment and improve patient response to cancer immunotherapies. Beyond oncology, Ju Microbial is advancing a pipeline of candidates targeting inflammatory bowel disease and metabolic conditions. By integrating high-throughput screening with advanced fermentation and formulation technologies, the company aims to provide innovative solutions for diseases with high unmet medical needs.